Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy by Giada Crescioli, Giada Crescioli, Marco Finocchietti, Olga Paoletti, Paola Brunori, Francesco Sciancalepore, Marco Tuccori, Marco Tuccori, Antonio Addis, Alfredo Vannacci, Alfredo Vannacci, Niccolò Lombardi, Niccolò Lombardi, Ursula Kirchmayer, The CAESAR study group

Get full text

Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure by Masaki Nakagaito, Teruhiko Imamura, Ryuichi Ushijima, Makiko Nakamura, Koichiro Kinugawa

“…We evaluated the risk factors for SGLT2i discontinuation in a real-world population with HF. Methods: We retrospectively included consecutive patients who were hospitalized for HF and administered SGLT2i during the index hospitalization between February 2016 and September 2021. …”
Get full text

Intracoronary lithotripsy in a high-risk real-world population. First experience in severely calcified, complex coronary lesions by Victoria Vilalta del Olmo, Oriol Rodríguez-Leor, Alfredo Redondo, Belén Cid-Álvarez, Eduard Fernández-Nofrerías, Xavier Carrill, Ramiro Trillo, Omar Abdul-Jawad Altisent, Xoan Sanmartín, Josepa Mauri, Jean Cristophe Barahona, Diego López-Otero, José Ramón González-Juanatey, Antoni Bayés-Genís

Get full text

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations by R. R. Cook, C. Foot, O. A. Arah, K. Humphreys, K. E. Rudolph, S. X. Luo, J. I. Tsui, X. A. Levander, P. T. Korthuis

“…Furthermore, trial participants may not represent “real-world” populations who would benefit from treatment. Methods We conducted a two-stage analysis. …”
Get full text

PB2027: PROGNOSTICATION IN THE EVERYDAY MYELOMA CLINIC. A SYSTEMATIC REVIEW OF PROGNOSTIC MODELS VALIDATED IN REAL WORLD POPULATIONS by L. Redder, T. Rosenberg, N. Hyldig, S. Möller, N. Abildgaard

Get full text

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population by C. B. Westphalen, M. G. Krebs, C. Le Tourneau, E. S. Sokol, S. L. Maund, T. R. Wilson, D. X. Jin, J. Y. Newberg, D. Fabrizio, L. Veronese, M. Thomas, F. de Braud

Get full text

Mitochondrially-Encoded Adenosine Triphosphate Synthase 6 Gene Haplotype Variation among World Population during 2003-2013 by Steven, Yoni F. Syukriani, Julius B. Dewanto

Get full text

Incidence and Predictors of Synchronous Bone Metastasis in Newly Diagnosed Differentiated Thyroid Cancer: A Real-World Population-Based Study by Lin Qi, Lin Qi, Wenchao Zhang, Wenchao Zhang, Xiaolei Ren, Xiaolei Ren, Ruiling Xu, Ruiling Xu, Chaoqian Liu, Chao Tu, Chao Tu, Zhihong Li, Zhihong Li

Get full text

Comparison of oral versus intravenous etoposide in the management of small‐cell lung cancer; A real‐world, population‐based study by Hatim Karachiwala, Derek Tilley, Omar Abdel‐Rahman, Don Morris

Get full text

Burden of hospitalizations in newly diagnosed heart failure patients in Poland: real world population based study in years 2013–2019 by Przemysław Leszek, Daniel Waś, Kinga Bartolik, Kladiusz Witczak, Andrzej Kleinork, Bohdan Maruszewski, Katarzyna Brukało, Paulina Rolska‐Wójcik, Małgorzata Celińska‐Spodar, Tomasz Hryniewiecki, Marta Załęska‐Kocięcka

Get full text

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study by Isabel Hurtado, Isabel Hurtado, Aníbal García-Sempere, Aníbal García-Sempere, Salvador Peiró, Salvador Peiró, Gabriel Sanfélix-Gimeno, Gabriel Sanfélix-Gimeno

Get full text

Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder by Palmer EOC, Ker S, Rentería ME, Carmody T, Rush AJ

Get full text

A Real-World, Population-Based Retrospective Analysis of Therapeutic Survival for Recurrent Localized Renal Cell Carcinoma After Nephrectomy by Sung Han Kim, Min Gee Choi, Ji Hye Shin, Young-Ae Kim, Jinsoo Chung

Get full text

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study by Swathi Pathadka, Vincent K. C. Yan, Xue Li, Xue Li, Xue Li, Gary Tse, Eric Y. F. Wan, Eric Y. F. Wan, Hayden Lau, Hayden Lau, Wallis C. Y. Lau, Wallis C. Y. Lau, David C. W. Siu, Esther W. Chan, Ian C. K. Wong, Ian C. K. Wong

Get full text

Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study by Lili Jiang, Tetyana Kendzerska, Shawn D. Aaron, Therese A. Stukel, Matthew B. Stanbrook, Wan Tan, Priscila Pequeno, Andrea S. Gershon

Get full text

The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study by Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, Tonny Studsgaard Petersen

Get full text

Fibrosis Quística: mutaciones más frecuentes en la población mundial Cystic fibrosis: more frequent mutations in world population by Teresa Collazo Mesa

Get full text

Evidence of housing instability identified by addresses, clinical notes, and diagnostic codes in a real-world population with substance use disorders by Daniel R. Harris, Nicholas Anthony, Dana Quesinberry, Chris Delcher

Get full text

Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study by Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison, Daniel Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani

Get full text

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization by Brandon Lu, Wei Fang Dai, Ruth Croxford, Wanrudee Isaranuwatchai, Jaclyn Beca, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Rebecca E. Mercer, Timothy P. Hanna, Kelvin K. W. Chan

Get full text